亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Gd(III)-nanodiamond conjugates as molecular imaging probes

技術優勢
10 times increase in relaxivity, thus, a significant increase in MRI contrast enhancementvery little impact of the hybrid complex on cellular viability, affirming the complex's inherent safety and biocompatibility.
詳細技術說明
Northwestern researcher have developed a gadolinium(III)-nanodiamond complex that, in a series of tests, demonstrated a significant increase in relaxivity and, in turn, a significant increase in contrast enhancement. #healthcare #imaging #therapeutics #drugdelivery #nanoparticles
*Abstract

Gadolinium (Gd) is the material most commonly used as a magnetic resonance imaging (MRI) contrast agent, but its contrast efficacy can be improved. Nanodiamonds has been demonstrated have excellent biocompatibility and can be used for efficient drug delivery. By coupling the contrast agent to a nanodiamond results in dramatically enhanced signal intensity and thus vivid image contrast. The Gd(III)-nanodiamond complex demonstrated a greater than 10-fold increase in relaxivity -- among the highest per Gd(III) values reported to date. A variety a nanodiamond samples have been imaged, including nanodiamonds decorated with various concentrations of Gd(III), undecorated nanodiamonds and water. The intense signal of the Gd(III)-nanodiamond complex was brightest when the Gd(III) level was highest.

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備